It may prevent the binding of the FOXO4 protein with p53, allowing p53 to bind with DNA and trigger apoptosis in senescent cells
Diarrhea and constipation are also commonly observed, each potentially affecting ten to fifteen percent of patients, with individual susceptibility varying based on factors such as baseline gastrointestinal function, dietary habits, and concurrent medications
Packaging: Sterile sealed vial
Related LIVV peptides and stacks LIVVs BPC-157 product page if you want to review it with a licensed provider
In preclinical studies, BPC-157 has been administered via subcutaneous injection, intramuscular injection, intraperitoneal injection, and orally (in drinking water)
For patients focused on fat loss and body recomposition, Perfect B typically runs the Wolverine Blend (BPC-157 + TB-500) alongside Tesamorelin